498 related articles for article (PubMed ID: 18926198)
1. Diagnosis of adrenocortical tumor in a neonate by detection of elevated blood 17-hydroxyprogesterone measured as a routine neonatal screening for congenital adrenal hyperplasia: a case report.
Hishiki T; Kazukawa I; Saito T; Terui K; Mitsunaga T; Nakata M; Matsuura G; Minagawa M; Kohno Y; Yoshida H
J Pediatr Surg; 2008 Oct; 43(10):e19-22. PubMed ID: 18926198
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of plasma androgen and estrogen concentrations in ferrets with hyperadrenocorticism.
Rosenthal KL; Peterson ME
J Am Vet Med Assoc; 1996 Sep; 209(6):1097-102. PubMed ID: 8800255
[TBL] [Abstract][Full Text] [Related]
3. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
[TBL] [Abstract][Full Text] [Related]
4. [Congenital adrenogenital syndrome and virilizing adrenocortical tumor in prepuberal females. Problems of diagnosis and therapy in 2 cases of virilization].
Bolesani C; Formentin PA; Zanon A; Lazzarato C; Lago F; Rigon F
Pediatr Med Chir; 1988; 10(3):305-13. PubMed ID: 2847120
[TBL] [Abstract][Full Text] [Related]
5. Infantile acne as the initial sign of an adrenocortical tumor.
Mann MW; Ellis SS; Mallory SB
J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S15-8. PubMed ID: 17097383
[TBL] [Abstract][Full Text] [Related]
6. Adrenal Tumor Mimicking Non-Classic Congenital Adrenal Hyperplasia.
Tsai WH; Wong CH; Dai SH; Tsai CH; Zeng YH
Front Endocrinol (Lausanne); 2020; 11():526287. PubMed ID: 33117272
[TBL] [Abstract][Full Text] [Related]
7. Screening and diagnosis of congenital adrenal hyperplasia in Basilicata (Italy).
Cordova RA; Vignola G
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():103. PubMed ID: 11400742
[TBL] [Abstract][Full Text] [Related]
8. Prenatal diagnosis of congenital lipoid adrenal hyperplasia.
Izumi H; Saito N; Ichiki S; Makino Y; Yukitake K; Kaneoka T
Obstet Gynecol; 1993 May; 81(5 ( Pt 2)):839-41. PubMed ID: 8469492
[TBL] [Abstract][Full Text] [Related]
9. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
Gu X; Zhou J; Ye J
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
[TBL] [Abstract][Full Text] [Related]
10. Limitations of 17-hydroxyprogesterone in investigating neonatal hyponatraemia.
Ismail AA; Cawood M; Ufodiama EB; Jones ST
Ann Clin Biochem; 2004 May; 41(Pt 3):245-7. PubMed ID: 15117442
[TBL] [Abstract][Full Text] [Related]
11. [Congenital adrenal hyperplasia: clinical aspects and neonatal screening].
Stikkelbroeck MM; Otten BJ
Ned Tijdschr Geneeskd; 2002 Feb; 146(6):246-9. PubMed ID: 11865652
[TBL] [Abstract][Full Text] [Related]
12. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
Schwarz E; Liu A; Randall H; Haslip C; Keune F; Murray M; Longo N; Pasquali M
Pediatr Res; 2009 Aug; 66(2):230-5. PubMed ID: 19390483
[TBL] [Abstract][Full Text] [Related]
13. [Neonatal levels of 17-hydroxyprogesterone--early diagnosis of adrenogenital syndrome].
Sulcová J; Tichá H; Wiererová O
Cesk Pediatr; 1989 Dec; 44(12):716-8. PubMed ID: 2636556
[TBL] [Abstract][Full Text] [Related]
14. Newborn screening for congenital adrenal hyperplasia in Sapporo City: sixteen years experience.
Mikami A; Fukushi M; Oda H; Fujita K; Fujieda K
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():100-2. PubMed ID: 11400741
[TBL] [Abstract][Full Text] [Related]
15. Pilot proficiency testing study for second tier congenital adrenal hyperplasia newborn screening.
De Jesús VR; Simms DA; Schiffer J; Kennedy M; Mei JV; Hannon WH
Clin Chim Acta; 2010 Nov; 411(21-22):1684-7. PubMed ID: 20619255
[TBL] [Abstract][Full Text] [Related]
16. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
[TBL] [Abstract][Full Text] [Related]
17. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
Gleeson HK; Wiley V; Wilcken B; Elliott E; Cowell C; Thonsett M; Byrne G; Ambler G
J Paediatr Child Health; 2008 Oct; 44(10):554-9. PubMed ID: 19012627
[TBL] [Abstract][Full Text] [Related]
18. Cortisol assay in dried blood spots to reduce false positive rate in congenital adrenal hyperplasia screening.
Brossaud J; Barat P; Fagour L; Corcuff JB
Clin Chim Acta; 2012 Aug; 413(15-16):1306-7. PubMed ID: 22561187
[No Abstract] [Full Text] [Related]
19. A case of virilizing adrenocortical carcinoma.
Takiuchi H; Oka T; Namiki M; Ichikawa Y; Sonoda T; Koga M; Sato B; Onishi S; Nakamura T; Matsushita H
Hinyokika Kiyo; 1987 Dec; 33(12):2090-4. PubMed ID: 2834927
[TBL] [Abstract][Full Text] [Related]
20. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
